Clinical Trial

EaveTubes for Vector Control

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 23, 2025 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this clinical trial is to test whether In2Care EaveTubes (ETs) as a stand-alone tool can reduce malaria in an area where transmission is driven by insecticide-resistant Anopheles gambiae. Children who live in homes with ETs will be monitored for malaria infection and compared to children living in homes without ETs in Côte d'Ivoire where there is universal coverage of long lasting insecticide nets and pyrethroid resistance is high.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-02-10; most recent amendment 2025-05-20.
Status change: Not Yet Recruiting → Active, Not Recruiting 2023-11-28
Trial Details
NCT Number NCT05736679
Lead Sponsor University of Notre Dame
Collaborators: Institut Pierre Richet, In2Care
Conditions Malaria
Enrollment 1,870 participants
Start Date 2023-03-23
Primary Completion 2025-12 (estimated)
Study Completion 2025-12 (estimated)
Updated on ClinicalTrials.gov 2025-05-23